Imaging News and Research

RSS

Donanemab may offer new hope for people with early Alzheimer's disease

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer's disease demonstrate an important advancement in Alzheimer's research and treatment.

17 Jul 2023

Donanemab shows promise in slowing Alzheimer's disease

With yet a third new Alzheimer's drug expected to be approved by the Food and Drug Administration (FDA), the field is beginning to show progress in the fight to slow the disease.

17 Jul 2023

The infection connection: investigating the impact on dementia risk, neuroimaging reveals

Researchers compared the association between neuroimaging markers of dementia and antibodies to common infection.

17 Jul 2023

New EULAR points-to-consider can help identify people at risk of psoriatic arthritis

The transition from psoriasis to PsA - and the early diagnosis of PsA - is of considerable scientific and clinical interest. People typically have psoriatic skin disease for a decade or more before they begin to experience the joint involvement of PsA.

17 Jul 2023

Predicting kidney abnormalities in utero with deep learning

Researchers examine the potential use of deep learning models to diagnose fetal kidney anomalies.

17 Jul 2023

DFG funds new clinical research unit to study autoimmune-mediated neurological diseases

How do neurological disorders arise that are caused, triggered, or influenced by antibodies? What better possibilities are there for diagnosis – and above all for treatment? These are the questions addressed by the new Clinical Research Unit "BecauseY" headed by Charité – Universitätsmedizin Berlin. Innovative treatment options will especially benefit patients who at first glance are not suspected of having an antibody-mediated neurological disease.

14 Jul 2023

Scientists discover new mechanism for kidney cell renewal

University of Texas at Dallas scientists have discovered a previously unknown "housekeeping" process in kidney cells that ejects unwanted content, resulting in cells that rejuvenate themselves and remain functioning and healthy.

14 Jul 2023

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

Researchers identified the anti-SARS-CoV-2 function of phospholipid scramblase 1 (PLSCR1).

14 Jul 2023

Empowering healthcare with AI: LungDiag NLP system transforms respiratory disease diagnosis

An artificial intelligence (AI) -based diagnostic system, LungDiag, to diagnose respiratory diseases.

14 Jul 2023

Study uncovers pathogenic variants in the chromatin modifier EZH1 as the cause of neurodevelopmental disorders

Study identified pathogenic variants in the EZH1 as a cause of neurodevelopmental disorders.

14 Jul 2023

AI tool accurately counts brain lesions on MRI scans within seconds

An artificial intelligence (AI) tool developed at The University of Texas Health Science Center at San Antonio accurately counts brain lesions on MRI scans within seconds.

13 Jul 2023

Synoptic reports improve completeness of pretreatment CT reports in advanced ovarian cancer

According to an accepted manuscript published in the American Journal of Roentgenology (AJR), a synoptic report improved completeness of pretreatment CT reports in patients with advanced ovarian cancer, including for established sites of unresectable or challenging-to-resect disease.

13 Jul 2023

Monumental $11.5 million gift will enable FAU to find a cure for amyloidosis

Currently, there is no cure for amyloidosis, a life-threatening disease that can be present throughout the body, including the heart, kidneys, liver and brain. The most common localized form of amyloidosis, which is seen significantly more often, is in the brain.

13 Jul 2023

Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test

Health care providers and their patients could know with greater confidence whether pancreatic cysts are benign or potentially malignant, and if surgery is required to remove them, by using a new diagnostic test currently in development.

12 Jul 2023

Study finds link between gut bacteria and atherosclerosis

In a major Swedish study, researchers have discovered a link between the levels of certain bacteria living in the gut and coronary atherosclerotic plaques.

12 Jul 2023

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

On July 6, 2023, the U.S. Food and Drug Administration granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer's disease.

12 Jul 2023

World's first completely open- and crowd-sourced neuroscience experiment launched

Today, scientists from the Allen Institute for Neural Dynamics, a division of the Allen Institute, launched the world's first completely open- and crowd-sourced neuroscience experiment-;inviting researchers from around the world to publicly design a shared experiment that will run on the Allen Brain Observatory, as part of the Institute's OpenScope program.

11 Jul 2023

Study identifies a signature of risk for developing hypomania

Mania, in which mood and energy level are extremely elevated for at least a week, and hypomania, which is less severe and lasts at least four days, are the defining features of bipolar spectrum disorders (BSD) and can be the most disruptive symptoms.

11 Jul 2023

Study provides unprecedented insights into the complexity of large-scale neural networks

That experiences leave their trace in the connectivity of the brain has been known for a while, but a pioneering study by researchers at the German Center for Neurodegenerative Diseases (DZNE) and TUD Dresden University of Technology now shows how massive these effects really are.

11 Jul 2023

Photon-counting CT protocol shows promise for lung imaging

New CT technology allows for a comprehensive, simultaneous evaluation of lung structure and function, something not possible with standard CT, according to a study published in Radiology, a journal of the Radiological Society of North America.

11 Jul 2023

Previous
1
...
72
73
74
75
76
77
78
...
1094
Next

Imaging News and Research

Donanemab may offer new hope for people with early Alzheimer's disease

Donanemab shows promise in slowing Alzheimer's disease

The infection connection: investigating the impact on dementia risk, neuroimaging reveals

New EULAR points-to-consider can help identify people at risk of psoriatic arthritis

Predicting kidney abnormalities in utero with deep learning

DFG funds new clinical research unit to study autoimmune-mediated neurological diseases

Scientists discover new mechanism for kidney cell renewal

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

Empowering healthcare with AI: LungDiag NLP system transforms respiratory disease diagnosis

Study uncovers pathogenic variants in the chromatin modifier EZH1 as the cause of neurodevelopmental disorders

AI tool accurately counts brain lesions on MRI scans within seconds

Synoptic reports improve completeness of pretreatment CT reports in advanced ovarian cancer

Monumental $11.5 million gift will enable FAU to find a cure for amyloidosis

Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test

Study finds link between gut bacteria and atherosclerosis

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

World's first completely open- and crowd-sourced neuroscience experiment launched

Study identifies a signature of risk for developing hypomania

Study provides unprecedented insights into the complexity of large-scale neural networks

Photon-counting CT protocol shows promise for lung imaging

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News